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ABSTRACT 
Effects of a Synthetic Cannabinoid on the Reinforcing 
Efficacy of Ethanol in Rats 
by 
Ericka M. Bailey, Master of Science 
Utah State University, 2007 
Major Professor: Dr. Amy L. Odum 
Department: Psychology 
The co-abuse of alcohol and marijuana is widespread, although the mechanisms 
underlying this behavior are unclear. There is some evidence of a relationship between 
the neural processes that mediate the effects of ethanol and marijuana. For example, 
research has shown that exposure to marijuana increases responding for, and intake of, 
ethanol. The alcohol deprivation effect is an anima l model of alcoholism that sugge sts 
that the reinforcing efficacy of etha nol , as measured by intake, increases following a 
period of deprivation . Recent research indicates that rats chronically exposed to 
marijuana during periods of alcohol deprivation consume ethanol above and beyond 
11 
deprivation alone. It is unclear, however, whether the marijuana exposure or the repeated 
deprivations increased motivation to consume ethanol. In the present experiment, rats 
were trained to self-admi nister ethanol on a progressive ratio schedule and subjected to 
Ill 
two separate periods of deprivation during which either drug or saline was chronically 
administered for 7 days. Breakpoint (i.e., last ratio completed) was recorded as a measure 
of the reinforcing efficacy of ethanol. Following deprivations, breakpoint was initially 
lower than baseline, regardless of whether the drug or saline was administered. 
Breakpoint recovered to, but did not exceed, baseline levels following both deprivations, 
indicating a lack of increased reinforcing efficacy of ethanol after repeated deprivation or 
chronic exposure to marijuana. The lack of an expression of an alcohol deprivation effect 
following deprivation may have been due to the length and number of deprivations 
employed. Furthermore, lowered breakpoint recorded following chronic drug 
administration during deprivation may have been due to the dose administered or stress 
generated by chronic injections . Further investigation is necessary to separa te and clarify 
the variables responsible for the present results. 
(62 pages) 
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INTRODUCTION 
Individuals who abuse one drug often abuse a second drug at or near the same 
time. The abuse of both marijuana and alcohol is especially common. Alcohol is easily 
obtained, particularly if one is at or over the legal age of 21. Although marijuana is 
illegal, it is easily obtained relative to other illicit drugs such as cocaine or heroin. The 
number of persons admitted to inpatient treatment for drug addiction who report the use 
of marijuana with alcohol is sufficiently high to warrant investigation into the processes 
underlying the co-abuse of the two drugs. 
In experimental settings, marijuana exposure increases ethanol consumption in 
nonhumans. Exposure to marijuana has also been shown to instigate relapse to drinking 
in subjects who have been alcohol deprived for a period of time. The process mediating 
the increase in motivation to seek or consume alcohol, however, is unclear. 
The behavioral and neural changes resulting from chronic exposure to ethanol 
have been investigated , implicating the involvement of neurotransmitter receptor 
systems, including the glutamatergic and GABAergic systems. Chronic ethanol exposure 
results in neuronal changes instigated by the brain in an attempt to maintain homeostasis. 
It is not known, however, if or how these neuronal changes may affect marijuana's ability 
to increase motivation to consume alcohol. 
Animal models of drug abuse suggest the participation of neural systems 
mediating drug abuse . Observations of behavior indicate an increase in the sensitivity to 
the effects of self-administered drugs following marijuana use. Subjects exposed to 
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marijuana prior to or in conjunction with self-administration of a drug respond for the 
drug sooner as well as consume more of the drug than subjects not exposed to marijuana. 
The endocannabinoid system in the brain is responsible for mediating the effects 
of marijuana. The active component in marijuana binds to the numerous cannabinoid 
receptors found mainly in the central nervous system. An internally produced 
cannabinoid receptor agonist normally activates these receptors and is responsible for 
mediating appetite, perception, and memory. The cannabinoid agonist has also been 
shown to increase levels of dopamine, a neurotransmitter involved in the rewarding 
properties of drug s of abuse. Marijuana, or its psychoactive components, mimics the 
effects of the internal cannabinoid and can substantially alter behavior. 
Exposure to marijuana can result in behavioral sensitization. After repeated 
exposure, smaller doses of the drug produce readily observable effects on behavior. 
Marijuana and ethanol have both been shown to induce behavioral sensitization in 
humans and nonhumans. Behavioral effects include slowed locomotor activity and 
repetitive or nonpurposeful movement. Long-term exposure to marijuana can also result 
in sensitization of the endocannabinoid system that mediates the effects of the drug. 
Specifically, relapse and/or increased intake of alcohol may result from changes in 
neuronal activity due to prior exposure to marijuana. 
Using human participants to investigate the underlying relation between 
sensitization and drug abuse is difficult and costly, as well as potentially ethically 
undesirable. The alcohol deprivation model is an animal model of drug abuse in which 
animal subjects engage in drug-related behavior similar to that exhibited by humans, 
including acquisition of stable drug self-administration as well as relapse. Experiments 
conducted with animal subjects in a controlled laboratory setting enable precise 
measurement of certain behavioral aspects of drug use. 
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One behavioral measure is the reinforcing efficacy of a drug. Reinforcing efficacy 
is measured by how much effort an organism puts forth to receive the drug. A progressive 
ratio (PR) schedule of reinforcement measures the effort expended by requiring an 
increa sing number of responses to obtain the drug. Progressive ratio schedules can also 
be used to study the effects of one drug on the reinforcing efficacy of another drug. 
Few studies have investigated how exposure to marijuana affects subsequent 
alcohol-related behavior. This experiment investigated the role of chronic exposure to 
marijuana on the reinforcing efficacy of self-administered ethanol. Previous research has 
indic ated that administration of a cannabinoid during alcohol deprivation results in an 
increa se in responding for alcohol as well as an increase in alcohol consumption. It is 
unclear , however, whether the increased reinforcing efficacy of alcohol was due to 
exposure to the cannabinoid or to the repeated aJcohol deprivation. In the present 
experiment, rats were trained to self-administer ethanol under a PR schedule of 
reinforcement. The reinforcing efficacy of ethanol was measured following baseline 
responding, a period of ethanol deprivation paired with chronic administration of a 
cannabinoid receptor agonist, and a period of ethanol deprivation paired with chronic 
administration of the drug vehicle. Subjects were exposed to the deprivation conditions in 
different orders. Within-subject behavior following each period of deprivation was 
measured and compared with the previous basei'ine. It was expected that the reinforcing 
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efficacy of ethanol, as measured by breakpoint, would increase following deprivation and 
furthermore that chronic exposure to a cannabinoid receptor agonist would increase the 
reinforcing efficacy of ethanol above deprivation alone. 
REVIEW OF THE LITERATURE 
Polydrug Abuse 
According to the 2003 National Survey on Drug Use and Health (Substance 
Abuse and Mental Health Services Administration, 2005), 21.6 million Americans were 
categorized as clinically dependent on, or abusing, drugs. Of these persons, 4.2 mjlJion 
abused marijuana, and 3.1 million reported being dependent on both alcohol and some 
illicit drug. The Community Epidemjology Work Group (CEWG, 2005) has reported 
widespread polydrug abuse in the United States. Polydrug abuse is gaining prevalence 
partly due to the availability and low cost of some illegal drugs. Marijuana continues to 
be the most used illicit drug and a large number of persons who abuse it report 
simultaneous abuse of alcohol. In 2000, state drug treatment facilities reported that 
patients who abused marijuana were more likely to also abuse alcohol than any other 
drug (CEWG) . According to the Substance Abuse and Mental Health Services 
Administration (SAMHSA), among persons admitted into drug treatment facilities for 
polydrug abuse in 2002, alcohol (76 %) and marijuana (55 %) were the most commonly 
abused drugs. 
Marijuana is often easier to obtain than other drugs of abuse partly due to its 
reputation as being less harmful than drugs such as cocaine, heroin, or even alcohol 
(Raphael, Wooding , Stevens & Connor, 2005). It is still an illegal substance, however, 
with the possibility of negative consequences attached to its use. The factors underlying 
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the polydrug abuse of marijuana and alcohol appear to be more complex than solely 
availability. Therefore, the increase in the abuse of marijuana, particularly with alcohol, 
has led researchers to investigate the possibility that neurological mechanisms, among 
other processes , play a role in polydrug abuse of this nature. 
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Humans who use marijuana and alcohol have reported that taking the drugs at or 
near the same time results in an additive drug effect that is more pleasurable than when 
either drug is taken alone (Lukas & Orozco, 2001). This effect could in part be accounted 
for by alcohol's ability to reduce or eliminate the negative subjective effects of 
marijuana, like paranoia. Marijuana may also alleviate nausea caused by increased 
alcohol consumption (Lukas & Orozco) . 
Experiments using animal subjects in a controlled setting have shown similar 
additive effects of marijuana and alcohol. Dar (2000) administered median doses of 
ethanol (1.0 g/kg) and the psychoactive component in marijuana , delta-9-
tetrahydrocannabinol (THC, 15 µg/kg), to rats to investigate the effects on motor 
coordination. Co-administration of ethanol and THC severely impaired coordination 
while the same dose of either THC or ethanol alone had no effect. While concurrent 
administration of marijuana and alcohol is of interest, it is also important to understand 
how the consumption of one drug affects the consumption of another drug taken later. 
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The Effects of Cannabinoid Exposure 
Several stud ies have shown that animals exposed to synthetic cannabinoid 
compounds (e.g., WIN 55,212-2 and CP 55,940) respond at an increased rate for alcohol 
as well as consume more alcohol. For exa mple, Colombo et al. (2002) showed an 
increase in ethanol self-ad ministratio n by selectively bred alcohol-preferring rats 
following acute administration of CP 55,940. Gallate, Saharov , Mallet, and McGregor 
( 1999) also showed that the motivation for beer in rats increased following acute 
administration of CP 55,940. 
Cannabinoids have also been shown to affect other aspects of dru g self-
administration. Acute expos ure to cannabinoids (e.g., THC, WIN 55 ,212-2 and CP 
55,940) has been show n to increase level s of responding for dru gs of abuse as well as the 
amount of the drug consumed following periods of extinction. In one study (Fattore, 
Spano, Cossu, Deiana , & Fratta, 2003) rats were trained to self-admini ster hero in. This 
behavior was then put on extinction for 21 days. Priming injection s of median doses of 
WIN 55,212-2 (0.3 mg/kg) or CP 55,940 (0.05 mg/kg) increased heroin-se eking behavior 
and consumption to levels substantially above pre-extinction level s. Acute administration 
of THC has also been shown to restore alcohol- seeking behavior following extinction 
(McGregor, Dam , Mallet, & Gallate, 2005) . Rat s were trained to self-administer beer and 
this behavior was subsequently put on ext inction. A median dose of THC (1.0 mg/kg) 
reinstat ed responding for the alcohol to significantly higher levels compared to 
responding durin g extinction. 
Early research showed that periods of alcohol deprivation increased responding 
for ethanol when it was available again (Sinclair & Senter, 1967). Cannabinoid pre-
exposure further increases responding for ethanol following periods of alcohol 
deprivation. Lopez-Moreno and colleagues (Lopez-Moreno, Gonzalez-Cuevas, 
Rodriguez de Fonseca, & Navarro, 2004) showed that rats chronically exposed to 
WlN 55,212-2 during 5 days of ethanol deprivation significantly increased their 
responding for ethanol above and beyond that after deprivation alone. Additionally, 
following 
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administration of 2.0 mg/kg or 10.0 mg/kg, responding at the end of the second week 
after deprivation was greater than after the first week suggesting that chronic 
administration of moderate or higher doses of cannabinoids extends the effects of alcohol 
deprivation. Together, these experiments suggest that cannabinoids increase the 
motivation to consume other drugs, including alcohol. 
Some conflicting results have also been found with regard to exposure to 
cannabinoids on responding for alcohol. In one experiment, a high dose of THC (10 .0 
mg/kg) administered acutely to rats prior to ethanol self-administration sessions 
decreased the amount of ethanol consumed compared to control (McMillan & Snodgrass, 
1991). The authors also reported that chronic administration of a range of doses (3 mg/kg 
to 30 mg/kg) decreased ethanol intake . If subjects had not received THC within 24 hours 
of a test session, however, ethanol intake was significantly higher than baseline. These 
results may reflect the well-documented biphasic effects of cannabinoids on motoric 
functioning or consummatory behavior. THC has been shown to increase activity at 
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lower doses (0 mg/kg to 3.0 mg/kg), while higher doses (5.0 mg/kg and higher) have 
been shown to initially retard functioning only to have it return some time after 
administration (e.g., Stark & Dews, 1980). Evidence of the biphasic effects of 
cannabinoids indicates that a high dose of THC administered soon before a session could 
decrease ethanol intake as well as motoric function. That is, motoric effects could be 
confounded with measures of consumption. Overall, the effects of marijuana on alcohol 
consumption highlight the need for an overarching explanation of the process underlying 
the effects of marijuana on later drug use, including alcohol use. Therefore, the effects of 
chronic ethanol consumption are initially discussed, followed by a review of neurological 
and behavioral effects of the psychoactive agent in marijuana. Then, the relationship 
between ethanol and cannabinoids at the neural level is examined. 
Neurological Effects of Chronic Ethanol Exposure 
Research suggests that the glutamate and gamma-aminobutyric acid (GABA) 
neurotransmitter and receptor systems play the most important roles in the neuronal and 
behavioral changes following chronic alcohol consumption (see Fadda & Rossetti, 1998, 
for review). Glutamate is the most widespread excitatory neurotransmitter in the brain 
and is responsible for rapid neurotransmission. Gamma-aminobutyric acid is the most 
widespread inhibitory neurotransmitter in the brain and effectively slows the "pace" of 
brain activity (e.g., Tsai, Gastfriend, & Coyle, 1995). Alcohol acts as an indirect 
antagonist on glutamatergic receptors and an indirect agonist on GABAergic receptors 
(e.g ., "Alcohol , the Brain, and Behavior: Mechanisms of Addiction," 2000). Therefore, 
when alcohol is chronically administered , the brain's effort to maintain homeostasis 
results in the alteration of receptor expression to balance the rate of neurotransrnis sion 
(Kelly, 1995). Chronic alcohol consumption results in a decrease in activated GABA 
receptors (i.e., downregulation) and an increase in activated glutamate receptors (i.e., 
upregulation ; Heinz , Schafer, Higley , Krystal, & Goldman, 2003). 
The Endocannabinoid System 
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A large body of neuropharmacological research has shown that the psychoactive 
agent in marijuana, THC, is activated when it binds to cannabinoid (CB 1) receptors 
concentrated in the central nervous system. Tetrahydocannabinol, as well as synthetic 
cannabinoid agonists like CP 55,940, is a receptor agonist. lt mimics the effects of the 
endogenous cannabinoid, anandamide, when it binds to cannabinoid receptors (Felder & 
Glass, 1998; Hungund & Basavarajappa, 2004). Anandamide is responsible for the 
regulation of several brain functions including appetite, memory, and motor control 
(Felder & Glass) as well as the process of dopamine transmission. Dopamine is a 
neurotransmitter that has been linked to the rewarding and motivational properties of 
reinforcers such as food and sexua l activity (e.g., Di Chiara, 1995) as well as drugs of 
abuse (e.g., Chaperon & Thiebot, 1999) . When cannabinoid receptor agonists come into 
contact with CB, receptors, the level of dopamine transmitted is increased above the level 
normally transmitted following anadamide binding (Chen et al., 1990) . Additionally, the 
effects of cannabinoid receptor ago nists on memory, appetite, perception , and so forth, 
are increased above anandamid e-i nduced effects. 
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Interaction of the Endocannabinoid System and Ethanol 
Studies have suggested that the endocannabinoid system mediates the effects of 
ethanol. Hungund , Szakall, Adam, Basavarajappa, and Vadasz (2003) showed that mice 
genetically altered such that they lacked CB 1 receptors (CB 1 knockout mice) consumed 
substantially less alcohol than their wild-type littermates. CB 1 knockout mice provide a 
model of drug-related behavior without the influence of the endocannabinoid system. 
Additionally, microdialysis measures showed no increase in dopamine release in the 
nucleus accumbens (NAcc; an area of the brain implicated in a major dopamine pathway) 
that generally follows ethanol administration indicating that the reinforcing efficacy of 
ethanol may be mediated by the endocannabinoid system. Thanos and colleagues also 
investi gated ethanol consumption using CB I knockout mice (Thanos, Dimitrakakis, Rice, 
Gifford, & Volkow, 2005). Two groups of mice (knockout mice and wild-type mice) 
were given acces s to both water and an ethanol solution in their home cages for 4 weeks. 
Once baseline intake of both fluids was determined , the CB 1 receptor antagonist 
SR141716A (Rimonabant) was administered . Receptor antagonists function by binding to 
cannabinoid receptor s and blocking cannabinoid receptor agonists (including 
anandamide) from binding to the receptor sites . Results showed that wild-type mice 
consumed more ethanol during baseline training phase than CB 1 knockout mice and that 
the administration of Rimonabant significantly decreased ethanol consumption in wild-
type mice but not CB 1 knockout mice. These results indicate that the deactivation of CB 1 
receptors by receptor antagonism decreases th~ reinforcing efficacy of self-admi nistered 
ethanol. Additional studies have examined the effects of Rimonabant on ethano l self-
administration and found that the antagonist substantially decreases ethanol intake in 
alcohol-preferring rats (Colombo et al., 1998). 
Neural Sensitization 
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The ability of a cannabinoid receptor antagonist to decrease alcohol consumption 
indicates an impo1tant relationship between alcohol and the cannabinoid system. 
Newman, Lutz, Gould, and Domino ( 1972) demonstrated that rats made tolerant to the 
behavior attenuating effects of THC during a shock-avoidance procedure also rapidly 
became tolerant to the sedative effects of alcohol during the same procedure. 
Basavarajappa and Hungund (1999) showed that human neuroblastoma cells chronically 
exposed to ethanol increased production of anandamide. Furthermore, administration of 
Rimonabant to the same cells ceased all production of anandamide. These results suggest 
that the activity of endogenous cannabinoids and the receptors that they bind to is 
facilitated by the presence of ethanol. 
When cannabinoids are administered, they mimic the effects of anandamide, but 
also alter the level of dopamine normally activated by anandamjde. Changes in behavior 
have been associated with changes in the level of dopamine release (see Chaperon & 
Thiehot, 1999, for a review). The abuse of marijuana has also been linked with changes 
in CB 1 receptor activation . 
Repeated exposure to a cannabinoid can cause a decrease in the number of 
receptors to which the cannabinoid can effectively bind, resulting in tolerance to the 
effects of cannabinoids (Romero et al. , 1998). Early research with THC demonstrated 
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that doses as large as 36 mg/kg had no effect on food-reinforced responding in pigeons 
following repeated administration of increasing drug doses (McMillan, Harris, 
Frankenheim, & Kennedy, 1970). Additionally, research has shown that chronic ethanol 
exposure in laboratory mice can result in the downregulation of CB I receptors 
(Basavarajappa, Cooper, & Hungund, 1998). Following ethanol exposure by inhalation 
for 4 days, administration of CP 55,940 showed substantially decreased drug/receptor 
binding activity although the binding affinity of the remaining receptors was not affected. 
Downregulation of CB I receptors could affect consumption of alcohol following 
cannabinoid administration. As the neural processes mediating marijuana and alcohol 
abuse are at least peripherally connected, then decreasing the number of binding sites for 
cannabinoids could lead to an increase in motivation for alcohol. 
Evidence of neural sensitization has also been found following high dose chronic 
exposure to THC (5 mg/kg to 40 mg/kg). Rubino, Vigano, Massi, and Parolaro (2003) 
demonstrated through autoradiographic brain imaging that cannabinoid receptors in 
certain areas of the brain were functionally altered even 3 weeks after the last dose of 
THC. Brain imaging showed an increase in CB I receptor binding of the administered 
cannabinoid (CP 55,940) in two areas known to have very high CB 1 receptor densities 
(i.e ., the cerebellum and caudate putamen). As the two areas are known to be involved in 
motor functioning, it is clear that changes occurring in these areas could result in 
observable changes in behavior due to sensitization. 
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Behavioral Sensitization 
It has been suggested that the mechanisms involved in the expression of the 
effects of a drug become "plastic" with repeated administration (e.g., Stewart & Badiani, 
1993). That is, biological and neurobiological changes occurring as a result of chronic 
drug administration most likely play a role in the effects of the drug expressed 
behaviorally. When chronic administration of a drug ceases for a period of time, behavior 
following a smaller dose will often resemble previous behavior following a larger dose. 
Diana , Melis, Muntoni , and Gessa (1998) demonstrated the plastic nature of neural 
systems involved in the expression of the effects of cannabinoid agonists and antagonists. 
They showed that the administration of Rimonabant to rats that had been chronically 
exposed to THC resulted in behavior indicative of "withdrawal" (i.e., facial rubbing, wet 
dog shakes, licking, etc.). Additionally , electrophysiological recording revealed a 
decrease in dopamine activity in the NAcc. Subsequent administration of THC ceased 
withdrawal-induced behavior and increased dopamine activity . When Rimonabant was 
administered to control rats (no THC exposure), they showed no behavioral signs of 
withdrawal and dopamine activity was not affected. These results suggest that chronic 
exposure to a cannabinoid sensitizes the cannabinoid receptors so that they are more 
susceptible to the effects of a cannabinoid antagonist. 
Much of the research on behavioral sensitization has focused on measuring 
increases in locomotor activity and/or stereotypy following the administration of a 
psycho motor stimulant. Rubino, Vigano, Massi, and Parolaro qoo l) chronically 
administered THC (5.0 to 40.0 mg/kg) to rats. Following a period during which no drugs 
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were administered, a challenge dose of 5.0 mg/kg was administered to all subjects. Rats 
exposed to THC spent substantially more time engaged in stereotyped behaviors (e.g., 
licking , gnawing, purposeless confined area sniffing) than those that initially received 
vehicle. Similar results were found with rats using smaller doses of THC (2.0 to 8.0 
mg/kg ; Cadoni, Pisanu, Solinas, Acquas, & Di Chiara, 2001). The indication that 
behavioral changes can occur following the administration of a relatively small amount of 
a cannabinoid is important, especially with regard to human marijuana use. For example, 
it may be possible for a short exposure to, or a small amount of , a cannabinoid agonist to 
substantially affect immediate as well as long-term behavior. 
Animal Models of Relapse 
Animal models of relapse have been widely used for some time (Carroll & 
Comer, 1996). Based on the data obtained during animal studies, inferences can be made 
regarding human drug abuse . For example, the alcohol deprivation model provides 
evidence for the restoration of previously maintained alcohol self-administration 
following a period of alcohol deprivation (Sinclair & Senter, 1967). Self-administration is 
recovered by allowing access to alcohol. Further, animals that have been deprived of 
alcohol following reliable alcohol self-admini stra tion consume substantially greater 
amounts of alcohol soon after it has been made available again than animals that have 
had continuous access to alcohol. 
The reinstatement model has also been shown to parallel aspects of human 
relapse , including the ability of a relatively small drug dose to instigate a return to drug-
related responding (Carroll, 1998). Reinstatement refers to behavior initially maintained 
by drug self-administration that is then extinguished and restored later by administering 
the same drug or a drug from a different pharmacological class. The ability of a drug to 
reinstate responding following extinction was first demonstrated by Stretch and Gerber 
(1973). Self-administration of d-amphetamine by monkeys was extinguished and 
subsequently reinstated with priming doses of d-amphetamine immediately prior to test 
sessions. In a later experiment, Gerber and Stretch (1975) showed that different drugs 
from the same pharmacological class could reinstate self-administration. They trained 
squirrel monkeys to self-administer cocaine, followed by extinction sessions in which 
cocaine was replaced with saline. During reinstatement testing, d-amphetamine was 
administered immediately before the beginning of a session in which only saline was 
available. d-Amphetamine dose-dependently increased response rate and number of 
saline infusions per session for cocaine well above extinction rates. 
16 
Drugs from one pharmacological class have also been shown to reinstate behavior 
originally maintained by drugs from a different pharmacological class. de Wit and 
Stewart were the first researchers to demonstrate this phenomenon with drug self-
administration (de Wit & Stewart, 1981). They showed that acute injections of 
amphetamine, morphine and apomorphine produced dose-dependent increases in 
responding during extinction sessions following cocaine self-administration. 
Reinstatement of responding following injections of morphine and apomorphine was not 
as high as following amphetamine. The fact that drugs known for their depressant 
behavioral effects were able to reinstate behavior initially maintained by a stimulant 
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suggested that neural systems mediating drug effects might be interacting (see Corchero, 
Manzanares, & Fuentes, 2004, for a review). de Wit and Stewart proposed that the 
mechanism underlying some aspect of reinstatement might be that the drugs shared 
neural sites of action. Therefore, administration of one drug could affect the value of a 
second drug. One way to measure the value of a drug as a reinforcer is by using a PR 
schedule. 
Progressive Ratio Schedule of Reinforcement 
A PR schedule of reinforcement is similar to a fixed ratio (FR) schedule in that a 
reinforcer is presented following a set number of responses. The PR schedule differs from 
the FR by requiring an increasing response output within the session to receive 
reinforcement (Hodos, 1961 ). The PR schedule was designed to distinguish the 
reinforcing strength or efficacy of a reinforcer from the rate of responding for the 
reinforcer (see Richardson & Roberts, 1996; Stafford, LeSage, & Glowa, 1998, for 
reviews). For example, if the concentration of a self-administered drug is increased, the 
rate of drug intake (directly related to responding) decreases even though the overall 
amount of the drug consumed may be high. A drug may have value for an organism, but 
pharmacological effects can be such that high rates of responding are difficult or 
impossible. Therefore, response rate does not necessarily reflect reinforcing efficacy. 
In a PR schedu le, reinforcer efficacy is determined by the measure of 
"breakpoint." Breakpoint is defined by the last ratio completed before the subject stops 
responding (under specified criteria) or the sessio n time is up. Breakpoint is sensitive to 
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both reinforcer magnitude and the level of motivation related to obtaining the reinforcer 
(Hodos & Kalman, 1963; Solinas & Goldberg, 2005). Therefore, the reinforcing efficacy 
of the drug is measured as opposed to direct pharmacological effects on behavior. 
Progressive ratio schedules used in experiments investigating ethanol self-
administration often employ an arithmetic increase in ratio size (Gomez & Meisch, 2003; 
Rodd et al., 2003, for example). This type of an increase may be desirable over the 
exponential increa se proposed by Robert s and Bennett (1993) as such marked increases 
in work requirement from one ratio to the next might result in the inability of the subjects 
to respond fast eno ugh to consume pharmacologically effective doses of ethanol in an 
appropriate amount of time (i.e., before it is metabolized). Therefore, a small increase in 
step size facilitates self -admini stration of an effective amount of ethanol during a session. 
Additionally, work requirement continues to increase and breakpoint can be measured . 
Progressive ratio schedules are widely used as a way to determine the reinforcing 
efficacy of a self-admi nistered drug (see Stafford et al., 1998, for review) . The measure 
of reinforcing efficacy often follows some kind of pre-exposure to a drug and can be used 
to test the effectiveness of a drug therapy for drug abuse or assess different variables 
involved in polydrug abuse. For example, a drug designed to attenuate responding for 
ethanol could be administered prior to a session in which ethanol is available under a PR 
schedule. A decrease in breakpoint compared with baseline measures would suggest that 
the drug decreas ed the reinforcing efficacy of ethanol. 
Rationale for Present Experiment 
Cannabinoid receptor agonists have been shown to alter subsequent drug-related 
behavior (e.g., Colombo et al., 2002). Both chronic and acute exposure to cannabinoid 
agonists increase responding for ethanol. Gallate et al. (1999) showed that acute 
administration of CP 55,940 increased the reinforcing efficacy of alcohol and a 
nonalcoholic fluid as measured by a PR schedule. Drug administrations, however, were 
separated by a single day in which no drug was administered . While the order of drug 
dose and vehicle was randomized, previous literature suggests that the effects of 
cannabinoid exposure may last longer than a day (Huestis, 2005). Thus, behavior 
measured following the seco nd dose of CP 55,940 may have been influenced by the first 
dose administered . 
The biphasic effec ts of cannabinoids have been well documented (e.g., Stark & 
Dews , 1980). Further, cannabinoids can produce a general increase in appetite soon after 
exposure. For examp le, Williams and Kirkham (2005) showed that the administration of 
a cannabinoid agonist increased the motivation for food in presatiated rats. Similarly, 
cannabinoid administration increases the motivation to eat sweet foods in humans 
(Matte s, Engelman, Shaw, & Elsohly, 1994). Therefore, in the present experiment, 
behavioral measurements did not occur during the acute effects of the cannabinoid 
agonist. 
Chronic administration of a cannabinoid agonist during a period of alcohol 
deprivation has been shown to increase the reinforcing efficacy of ethanol when it is 
made available again. Lopez-Moreno and colleagues (2004) showed that when subjects 
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were allowed access to ethanol under an FR l schedule following an initial period of 
deprivation, the rate of responding increased substantially above baseline. A second 
period of deprivation was paired with chronic administration of a cannabinoid that 
resulted in an increase in responding that exceeded the response increase following 
deprivation only. Further, the increase in responding measured after cannabinoid 
exposure was longer lasting than deprivation only. The results, however, may have been 
due to an artifact of the experimental design rather than due to exposure to the 
cannabinoid agonist. That is, all subjects trained to self-administer ethanol were first 
exposed to a period of deprivation only. This period was followed by re-exposure to the 
ethanol self-administration procedure. Finally, all subjects were deprived of ethanol for a 
second time while receiving chronic injections of a cannabinoid. The authors concluded 
that changes in the CB 1 receptors due to chronic exposure to the cannabinoid were most 
likely responsible for the more robust and longer-lasting increase in responding for 
ethanol. 
This explanation does not take into account, however, possible procedural 
sequence effects when conducting more than one experimental condition. One possible 
effect is that subjects have already experienced one condition prior to being exposed to 
the second, which could influence outcomes following exposure to the second condition 
(see Kazdin, 1982). Previous research has shown that ethanol self-administering rats 
subjected to multiple periods of alcohol deprivation increase responding for ethanol 
across successive deprivation periods (e.g., Rodd et al., 2003). Therefore, sequence 
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effects need to be controlled to provide an accurate assessment of the increase in the 
reinforcing efficacy of ethanol following chronic administration of a cannabinoid agonist. 
Lopez-Moreno and colleagues (2004) used an FR 1 schedule to measure response 
rates following alcohol deprivation conditions and found increased responding for 
ethanol following alcohol deprivation paired with administration of a cannabinoid. Fixed 
ratios measure rates of responding, which do not necessarily reflect the reinforcing 
efficacy of a drug. That is, an FR 1 may measure ethanol consumption, but not the 
motivation to consume ethanol. For example, high rates of responding for a drug on an 
FR 1 schedule can occur even when the reinforcing efficacy of a drug is relatively weak . 
Progressive ratio schedules are a widely accepted measure of the reinforcing efficacy of a 
drug during self-administration procedures (see Richardson & Roberts, 1996, for review) . 
Progressive ratios incorporate increasing work requirements for drug reinforcement, and 
the direct pharmacological effects of a drug on behavior are minimized during sessions. 
Therefore, the present experiment used a PR schedule to measure the reinforcing efficacy 
of ethanol following each deprivation condition. 
The present experiment investigated the effects of the synthetic cannabinoid 
receptor agonist, CP 55,940 on the reinforcing efficacy of ethanol during a self-
administration procedure. Synthetic cannabinoid agonists have been shown to affect 
behavior in the same or similar ways as the natural cannabinoid agonist, THC, and are 
more readily available for research purposes. Administration of the synthetic agonist, CP 
55,940 has been shown to dose-dependently substitute for THC in discriminative 
stimulus tests (Wiley, Barrett, Lowe, Balster, & Martin, 1995) . Additionally, rates of 
responding under the effects of CP 55,940 did not differ from rates under the effects of 
THC. Behavior on a simple schedule of reinforcement was similarly affected following 
administration of four cannabinoid agonists, including THC and CP 55,940 (Carriero et 
al., 1998). 
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At this time, the effects of cannabinoids on the reinforcing efficacy of self-
administered ethanol are unclear. Despite recent research the effect of cannabinoid 
exposure per se, above and beyond the effects associated with repeated alcohol 
deprivation, are not clear. Therefore, the present experiment examined the effects of 
chronic administration of the synthetic cannabinoid agonist CP 55,940 during a period of 
alcohol deprivation on the reinforcing efficacy of subsequently available ethanol. 
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STATEMENT OF THE PROBLEM 
Alcohol and marijuana are frequently used in combination. An increasing number 
of studies have been addressing the hypothesis that the psychoactive component in 
marijuana increases consumption of many different drugs of abuse, including alcohol. 
The processes underlying this behavior are still unclear. 
The endocannabinoid system has been thought to mediate the effects of alcohol 
for some time . Promotion or disruption of receptor activity in this system can alter the 
motivation to consume alcohol and change the amount consumed. Specifically, 
cannabinoid receptor agonists (e.g., THC, CP 55,940) have been shown to increase 
ethanol consumption (Colombo et al., 2002; Gallate et al., I 999). Further, the 
cannabinoid receptor antagonist Rimonabant substantially decreases ethanol intake in rats 
previously trained to self-administer ethanol (Freedland, Sharpe, Samson, & Porrino, 
2001; Thanos et al. , 2005). 
Few studies have add1:essed the effects of chronic administration of a cannabinoid 
receptor agonist on the reinforcing efficacy of ethanol. Recent research, however, has 
shown that chronic exposure to a cannabinoid receptor agonist during alcohol deprivation 
can restore responding for alcohol above baseline performance (Lopez -Moreno et al., 
2004). The process mediating the increase in motivation to consume ethanol following 
cannabinoid exposure is still unclear. The present experiment attempted to separate the 
effects of chronic administration of a cannabinoid agonist from the effects of multiple 
periods of alcohol deprivation on the reinforcing efficacy of ethanol. The alcohol 
deprivation model (an accepted animal model of drug relapse) and the PR schedule (a 
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widely used measure of the reinforcing efficacy of drugs of abuse) were used to examine 
whether the endocannabinoid system mediates the reinforcing efficacy of self-
administered ethanol. 
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METHOD 
Subjects 
Eight experimenta lly nai've Long Evans rats served as subjects. Three subjects 
were removed from the study during ethanol self-administration training when they 
stopped responding for the ethanol solution. Rats were individually housed in a 
temperature- and humidity-controlled room on a 12-h light!dark cycle. Upon arrival, 
subjects were handled daily and were given free access to food in the home cages for 2 
weeks followed by food restriction. Subjects were maintained at approximately 80% of 
their ad libitum weight(± 15 g), which was achieved by assessing weight daily and 
postsession supplemental feedings. Water was freely available in home cages throughout 
the experiment. 
Design 
The present experiment was conducted using counterbalancing procedures in 
which all subjects experienced two conditions and the order of exposure to each 
condition varied across subjects. This type of within-subject design was chosen to allow 
for assessment of the possible influence of sequence effects with regard to conditions. 
That is, each subject experienced all conditions in the experiment and therefore served as 
its own control (Keppel, 1991). Following baseline training , subjects were assigned to 
Group l or Group 2. 
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Apparatus 
Eight Med Associates® operant conditioning chambers were used. Dimensions of 
chambers 1 through 4 were as follows: Each chamber was approximately 30 cm long, 24 
cm wide, 29 cm high, and housed in a sound-attenuating cubicle. The front panel of each 
chamber was equipped with two response levers centered 13 cm apart. Each chamber 
contained a 28-V houselight at the top center of the front panel, a sonalert (2900 ± 500 
Hz, 75-85 dB), a solenoid-operated dipper located between the two levers that delivered 
the liquid solutions, and light emitting diodes (LEDs) in a horizontal array of red, yellow, 
and green lights located above each lever. During dipper presentations, lever lights and 
houselights were darkened. A light inside the opening for the dipper activated during 
dipper presentations. Extraneous noise was masked by a chamber vent ilation fan and 
white noise. Dimensions of chambers 5 through 8 were the same as l through 4, except 
that the height was 21 cm. Control of experimental events and data recording were 
conducted in an adjacent room with Med Associates® interfacing and programming. 
Procedural Overview 
Subjects were trained to respond for ethanol under a PR schedule. When 
responding was deemed reliable, subjects were matched into pairs based on their rank for 
breakpoint. Pairs were separa ted and assigned to Group 1 or Group 2 and the fifth 
unmatched subject was randomly assigned to Group 2. Matching was used to control the 
influence of the reinforcing efficacy of ethano l (measured by the last ratio completed) 
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between subjects prior to alcohol deprivation conditions. Group 1 was exposed to ethanol 
deprivation plus vehicle administration (condition A) first and ethanol deprivation plus 
cannabinoid administration (condition B) second. Group 2 was exposed to ethanol 
deprivation plus cannabinoid administration (condition B) first and ethanol deprivation 
plus vehicle administration (condition A) second. Both conditions involved twice daily 
injections of either vehicle or cannabinoid agonist for 7 consecutive days (i.e., chronic 
administration). The reinforcing efficacy of ethanol was measured after each deprivation 
period. On the third day following the last injection (cf. Lopez-Moreno et al., 2004), 
access to ethanol was made available again under a PR schedule. 
Procedure 
Ethanol Self-administration Training 
Subjects were trained to self-administer ethanol using a fading procedure in which 
increasing amounts of ethanol are gradually added to a sucrose solution, while the 
sucrose is gradually faded out (Samson, 1986). All subjects were initially exposed to a 
variable time (VT) 60 s schedule to train rats to drink a 10% sucrose solution available 
during dipper presentation . Then, rats were trained to respond on a lever for the solution 
under a random-ratio 2 (RR 2) schedule of reinforcement in which the probability of each 
response resulting in reinforcement was .50 (see Latta!, 1991). At this time, only one 
lever in each chamber was programmed as "active." That is, responses on the active lever 
resulted in the presentation of the dipper containing 0.1 ml of a 10% sucrose solution, 
while responses on the inactive lever we1:e recorded but had no programmed 
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consequences. The active lever was signaled by illumination of the LEDs above the lever. 
Response s on active and inactive levers were recorded for the entire experiment. Active 
lever s were counterbalanced across subjects to minimize the possibility of the influence 
of a side bias. Immediately following rapid 
responding under the RR 2, the ratio value was increased, usually during sessions until 
rapid, reliable responding occured on a RR 20 in which the probability of reinforcement 
following each respon se was .05. At this point, ethanol was slowly added to the sucrose 
solution, while the concentration of sucrose was decreased. The order of sucrose/ethanol 
concentrations was as follows: 10% sucrose in 0% ethanol v/v, 10% sucrose in 2% 
ethanol v/v, 10% sucrose in 5% ethanol v/v, 10% sucrose in 10% ethanol v/v, 8% sucrose 
in 10% ethanol v/v, 5% sucrose in 10% ethanol v/v, 3 % sucrose in 10% ethanol v/v, 1 % 
sucrose in 10% ethano l v/v, 0% sucrose in 10% ethanol v/v. Sessions were 30 min in 
length and the training phase for ethanol self-administration took approximately three-
and-a-half months. 
Ethanol Se(f-administration under a PR Schedule 
Following reliable responding (i.e ., no increasing or decreasing trends detected by 
visual inspection) for the 10% ethanol, 0% sucrose solution under the RR 20 schedule, 
ethanol presentations (0.1 ml) were determined by lever presses under a PR schedule of 
reinforcement. Under the PR schedule, requirements for reinforcement (ethanol) were 
increased within session after each dipper presentation. An arithmetic ratio increase was 
used such that the values of the steps were 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and so on. Each 
experimental condition consisted of a minimum of 15 sessions. Each session under the 
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PR schedule was programmed to end after 3 h or when 15 min had passed with no 
response on the active lever. Responding was considered stable in all conditions when the 
breakpoints during the final 5 sessions of a condition did not exceed or fall below the 
range of the breakpoints recorded during the previous sessions in the condition (e.g., the 
breakpoints for sessions 
11 through 15 fell within the breakpoints recorded during sessions 1 through 10; Stafford 
& Branch, 1998). 
CP 55,940 Exposure 
During Condition B, subjects received intraperitoneal (i.p.) injections of CP 
55,940 two times a day at approximately 8:00 a.m. and 8:00 p.m. for 7 days. 0.03 mg/kg 
CP 55,940 was administered in a volume of 1.0 ml/kg of the 80% free-feeding weight. 
This dose has been acutely administered in previous research and was found to increase 
breakpoint for responding for alcohol under a PR schedu le (Gallate et al., 1999). All 
subjects were removed from their home cages for injections and returned immediately 
following the procedure. During condition A, subjects received an equivalent volume of 
vehicle administered in the same manner as the CP 55,940. 
Drugs 
CP 55,940 (Sigma) arrived as 10 mg solid that was suspended in 
dimethyJsulfoxide (DMSO) and diluted in 0.9% saline. CP 55,940 was refrigerated 
between chro nic administration periods . Ethanol solution was prepared with 95% ethanol, 
distilled water and table sugar (when specified). Ethanol solutions were kept at room 
temperature during the entire experiment. 
Dependent/11easures 
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During the initial training sessions, the rate of responding as well as the intake of 
ethanol or sucrose so lution was measured. Rate of responding was measured as the 
number of lever presses per minute. The number of presses on the active and inactive 
levers was recorded during the length of the experiment to assess the specificity of any 
observed effects. Ethanol intake was measured as the number of dipper presentations per 
session. 
During PR schedule sessions, the breakpoint, or number of lever presses emitted 
to obtain ethanol , was defined as the last ratio completed that corresponded with the 
number of dipper presentations. Ethanol consumption was measured as g/kg determined 
by the g/kg of ethanol available in each 0.1 ml dipper (i.e ., 0.00793 g/kg). Sessions 
automatically ended when no responses occurred on the active lever for 15 min. All 
sessions for each subject during the entire experiment were less than 3 hr in length and 
generally did not last more than 1 hr (cf. Gomez & Meisch, 2003 ; Solinas et al., 2005). 
Responding was considered stable when the breakpoints during the final 5 sessions of a 
condition did not exceed or fall below the range of the breakpoints recorded during the 
previou s sessions in the condition. 
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RESULTS 
Figure 1 shows the pre- and postdeprivation breakpoint s for all rats that received 
chronic injections of CP 55, 940 during the periods of ethanol deprivation. The panels on 
the left show breakpoints for rats that received chronic injections of CP 55,940 during the 
first period of ethanol deprivation and the panels on the right show breakpoints for rats 
that received chronic injections of CP 55,940 during the second period of ethanol 
deprivation. Following the first and second deprivation periods, breakpoints were lower 
than the last breakpoint recorded during baseline. Breakpoint recovered to general 
baseline levels for all subjects by approximately the third session. No trend of increasing 
or decreasing breakpoint relative to baseline was seen during sessions 7 through 21. Once 
breakpoints reached approximate baseline levels, they remained relatively stable with one 
exception . Following the first deprivation, breakpoint for N67 was fairly variable through 
session 21. 
Figure 2 shows the pre- and postdeprivation breakpoints for all rats that received 
chronic injections of vehicle during the periods of etha nol deprivation. The panels on the 
left show breakpoints for rats that received chronic injections of vehicle during the first 
period of ethanol deprivation and the panels on the right show breakpoints for rats that 
received chronic injections of vehicle during the second period of ethanol deprivation. 
Following the first deprivation period, breakpoints were lower than approximate baseline 
levels for the first severa l sessio ns. Postdeprivation breakpoints recovered quickly, 
however, and sessions 7 through 2 l following deprivation showed no trend of increasing 
100 
80 
60 
40 
20 
0 
100 
......, 
80 c:: 
....... 
0 60 
°" ~ crj 
(1) 40 
I-< 
P:'.:l 20 
0 
100 
80 
60 
40 
20 
0 
CP 55,940 
Pre-dep Post-dep Pre-dep - Post-dep 
~ 
N67 
1 ~ /~ j ~ 
N69 N71 
3 5 7 9 11 13 15 17 19 21 
vv 
N72 
3 5 7 9 11 13 15 17 19 21 
Session 
Figure 1. Breakpoint before and after deprivations during which 
CP 55,940 was chronically administered. 
32 
100 
80 
60 
40 
20 
0 
100 
80 
60 
40 
20 
0 
Vehicle 
Pre-dep Post-dep Pre-dep Post-dep 
~ 
N68 N67 
3 5 7 9 11 13 15 17 19 21 
100 
80 
60 
40 
20 
O N72 
3 5 7 9 11 13 15 17 19 21 
Session 
Figure 2. Breakpoint before and after deprivations during which 
vehicle was chronically administered. 
33 
34 
or decreasing breakpoint relative to baseline. Performance for both subjects following the 
first deprivation was relatively stable with few exceptions of variability. Breakpoints 
following the second period of deprivation were initially lower than baseline levels. Once 
breakpoint recovered to approximate baseline levels, performance was relatively variable 
for subjects N67 and N69 , but remained fairly stable for N72 through session 21. 
Overall , breakpoint decreased relative to baseline for subjects that received 
chronic injections of CP 55,940 or vehicle during deprivation. Breakpoint was 
undifferentiated across periods of deprivation and injection type. The degree of decrease 
in breakpoint and the number of sessions breakpoint remained below baseline varied 
across subjects. Generally , once breakpoint had reached baseline levels, it remained 
relatively stable. 
Figure 3 shows the mean amount of ethanol made available in g/kg following the 
first and second periods of ethanol deprivation. Mean alcohol delivery was calculated 
separately for subjects that received vehicle or CP 55 ,940. The top panel shows the mean 
ethanol delivery before and after the first period of ethanol deprivation . Baseline delivery 
shows that rats that were to receive CP 55,940 during deprivation earned more ethanol 
than rats that were to receive chronic injections of vehicle . Following deprivation, ethanol 
delivery decreased relative to baseline for all rats . The amount of ethanol earned 
postdeprivation by rats that received vehicle, however, was substantially lower than the 
amount earned by rats that received CP 55,940 during the deprivation period. Ethanol 
delivery recovered to approximate baseline levels within several sessions and was 
undifferentiated across CP 55,940 or vehicle exposure. 
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The middle panel shows the mean ethanol delivery before and after the second 
period of ethanol deprivation. Baseline delivery shows that rats that received vehicle 
during deprivation earned more ethanol than rats that were to receive CP 55,940 during 
deprivation. Following deprivation, ethanol delivery decreased relative to baseline for all 
rats. The decrease in the amount earned by rats that received vehicle, however, was 
greater than the decrease in the amount earned by the rats that received CP 55,940. 
Approximate baseline delivery was recovered by the third session for rats that received 
vehicle and by the fifth session for rats that received CP 55,940. 
The bottom panel shows the overall mean ethanol delivery following both periods 
of ethanol deprivation. Ethanol delivery was calculated separately for CP 55,940 and 
vehicle. Results show that the amount of ethanol earned was similar across deprivations, 
subjects and vehicle or CP 55,940 administration. 
Figure 4 shows the mean proportion of baseline for breakpoint following the first 
and second period of ethanol deprivation. Proportion of baseline was calculated because 
baseline measures of breakpoint and g/kg ethanol earned varied substantially across 
subjects. The top panel shows the proportion of baseline following the first deprivation. 
The breakpoint decreased similarly for groups that received vehicle and CP 55,940 
during deprivation and remained relatively undifferentiated between groups through 
session 15. Breakpoint for both groups recovered to levels similar to baseline by the third 
session . There was some variability through session 15. 
The bottom panel shows the proportion of baseline following the second 
deprivation. Similar to the first session following the first deprivation, breakpoint was 
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initially lower than baseline following either vehicle or CP 55,940 administration. 
Breakpoint for both groups recovered to levels similar to baseline by the second session, 
but was relatively variable through session 15. Breakpoint was fairly undifferentiated 
between groups across sessions. 
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DISCUSSION 
The present results show an initial decrease in breakpoint relative to baseline 
following a period of ethanol deprivation . Additionally, responding for ethanol was not 
different following chronic administration of CP 55,940 or vehicle during ethanol 
deprivation. Therefore, these results indicate a decrease in the reinforcing efficacy of 
ethanol following deprivation, and that chronic administration of a cannabinoid receptor 
agonist during deprivation did not facilitate responding for ethanol following deprivation . 
Based on previous research, results of the present experiment were not what were 
expected . The alcohol deprivation effect (ADE) is a widely used animal model of 
alcoholism (see Rodd, Bell, Sable, Murphy, & McBride, 2004; Spanagel & Holter, 1999, 
for review). Research has shown that depriving a laboratory rat of access to ethanol for a 
period of time following extended , reliable ethanol consumption results in a temporary 
increa se in ethanol intake when it is made available again. The traditional laboratory 
methodology involve s comparing ethanol intake in rats that have had 24 h free-access to 
ethanol before and after a period of ethanol deprivation. For example, Sinclair and Senter 
(1967) first demonstrated the ADE in which rats were given 24 h free home-cage access 
to a 7% v/v ethanol solution for weeks 2, 4, 6, and 8 of the experiment. Rats in one group 
(i.e ., Group D) were deprived of ethanol during weeks 1, 3, 5, and 7 and rats in a second 
group (i.e., control) were not deprived of ethanol. The amount of ethano l consumed by 
Group D following periods of deprivation was substantially greater than the amount 
consumed by control rats, although the effect was short lived. Humans, however, are 
required to work in some capacity to obtain alcoho l. Therefore, it is unclear how free 
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access to ethanol can provide an accurate model of human alcohol abuse when no work is 
required of the subject(s). 
Operant procedures, in which subjects must fulfill some predetermined work 
requirement prior to reinforcement, have more recently been implemented in the study of 
the ADE. Samson and Chappell (2001) conducted two experiments in which they 
examined the effects of alcohol deprivation on intake of, and responding for, ethanol 
during a limited access operant procedure. Rats were required to complete an FR 30 prior 
to 20-min access to ethanol. A predeprivation extinction session was then conducted in 
which access to ethanol did not follow completion of the FR 30 . Once baseline 
responding was reestablished, rats were deprived of ethanol and kept in their home cages 
for 15 days. Following deprivation, an extinction session was conducted. Then, rats were 
allowed access to ethanol again after completion of an FR 4. Responding measured 
durin g the postdeprivation extinction session was significantly lower than during the 
predeprivation extinction sess ion. Additionally, ethanol intake following deprivation was 
slightly greater than intake before deprivation . The results of this experiment suggest that 
when work is required of the subjects (i.e., operant condition), neither increased 
respo nding nor ethanol intake indicative of an ADE is observed following a period of 
ethanol deprivation. Conversely, other experiments in which ethanol was available only 
under operant conditions have observed an ADE following deprivation. The reasons for 
these conflicting results are largely unclear; however, the imposition of a single period of 
deprivation may be a factor. The ADE model of alcohol abuse first proposed by Sinclair 
and Senter (1967) showed a substantial ADE occurring following a sing le period of 
deprivation. Alcoholism in humans, however, is often marked by multiple periods of 
abstinence ( e.g., McMillen, 1997). Therefore, recent experime nts have examined the 
effects of repeated periods of deprivation on the expression of an ADE. 
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Oster and colleagues (2006) recently examined the effects of multiple periods of 
alcohol deprivation on responding for ethanol by high-alcohol-drinking (HAD-1 and -2) 
rat lines. Utilizing an operant procedure, ethanol solution was available during 1 h 
sessions on an FR 5 schedule. Once responding was stable, rats were deprived of ethanol 
for O (control), 2, 5, or 8 weeks. Rats were then allowed access to ethanol on the operant 
schedule for 2 weeks followed by 2 weeks of deprivation. Three additional 2-week 
periods of access and deprivation followed. Re sponding for ethanol after the first period 
of deprivation was substantially below baseline levels for all rats. After the second 
deprivation, responding increased relative to the first deprivation, but was at or below 
baseline levels. A small increase above baseline levels was observed following the third 
deprivation; however, responding was not significantly above baseline until after the 
fourth deprivation . Consequently, three or more periods of deprivation were necessary to 
elicit an ADE in rats on an operant schedule. Therefore, it is possible that the two periods 
of deprivation imposed on subjects in the present experiment were not sufficient to result 
in the expression of an ADE, particularly when alcohol was available only under operant 
conditions. Related experiments have also shown that repeated periods of alcohol 
deprivation were necessary to elicit an ADE in two alcoho l-preferring rat strains even 
when 24 h free-access to ethanol was employed (Rodd -Hendricks, McKinzie, Murphy et 
al., 2000; Rodd-Hendricks , McKinzie, Shaikh, et al., 2000). 
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Research has indicated that the length, as well as the number, of deprivations may 
affect the expression of an ADE. Heyser, Schulteis, and Koob (1997) trained rats to 
respond during 30-min daily sessions for a 10% (w/v) ethanol solution on a continuous 
reinforcement schedule (CRF). Once responding was stable, rats were deprived from 
ethanol for 3, 5, 7, 14, or 28 days after which access to ethanol was resumed under 
previous conditions . Responding for ethanol increased as a function of the length of 
deprivation . Rats that were deprived of ethanol for 14 or 28 days responded significantly 
more for ethanol than rats deprived for 5 or 7 days. Periods of deprivation were 9 days 
long in the present experiment. Therefore, it is possible that the length of deprivation 
impo sed during the present experiment may not have been sufficient to elicit an ADE. 
Another factor that may have contributed to the present effects is stress. Different 
types of stress have been shown to facilitate or attenuate responding for ethanol in 
laboratory animals. At this time, the reasons for the differential effects are unclear. 
Research shows that exposure to some types of physical or psychological stressors results 
in an increase in responding for, or intake of, ethanol in rats . Conversely, research also 
shows that some types of stress result in a decrease in ethanol-related behavior. For 
example, van Erp and Miczek (2001) exposed rats to short-term, daily episodes of social 
defeat stress and examined the effects on subsequent ethanol consumption in operant and 
free-access conditions. The stress of social defeat resulted in a short-lived suppression of 
ethanol intake in both the operant and free-access rats. Furthermore, ethanol intake was 
suppressed both immediately following social defeat stress and several hours after 
exposure to the stressor. 
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A recent experiment examined the effects of different types of stressors on the 
ADE (Dayas, Martin-Fardon, Thorsell, & Weiss , 2004). Following ethanol self-
adrninistration training on an FR 3 schedule, rats were given a liquid diet containing a 
10% ethanol concentration for 21 days. After the liquid diet, rats were returned to the 
operant sess ions to obtain ethanol. Once responding for ethanol was stabilized, rats were 
deprived of ethanol for 7 days during which they were randomly separated into three 
groups. During deprivation, one group received daily, chronic, intermittent footshock. A 
second group received daily injections of a toxin that activates the hypothalamic-adrenal-
pituitary axis and is a model for chronic stress. A third group was exposed to no stressor 
(i.e ., control). Upon resumption of ethanol self -admini stration, responses per session 
were compared to responses prior to ethanol deprivation . Contro l rats exhibited an ADE 
in which respondin g during the first session was significantly higher than baseline. Rats 
that received chronic footshock exhibited no significant increase in responding following 
the deprivation period . Rats that received daily toxin injections responded significantl y 
less than baseline during the first session after deprivation and responding was 
suppressed for severa l days following deprivation. Thus , the effects of stressors on 
responding for ethanol are unclear at this time. The type of stressor, the length of 
exposure to stress, the context and contingency of access to ethano l, or a number of other 
variables, may diff ere ntially contribute to changes in ethanol-related behavior. 
Research has also shown that painful stimu li such as footshock increase ethanol 
consumption following periods of deprivation (Funk , Vohra, & Le, 2004). Additional 
research suggests that chronic saline injections can alter later responding for ethanol 
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(Slamberova, Schindler, & Vathy, 2002). To this author's knowledge, however, no 
research exists examining the effects of injection pain or stress on the manifestation of an 
ADE. In the present experiment, all subjects were exposed to two 9-day periods of 
ethanol deprivation during which time each received an i.p. injection of either CP 55,940 
or drug vehicle twice a day for the first 7 days. It is possible that the injections resulted in 
fear during injection or increased sensitivity of the injection site following multiple 
injections . Additionally, the removal of access to ethanol may have acted as a stressor 
and heightened sensitivity to the injections . It is therefore conceivable that the stress of 
multiple injections in addition to the stress related to the removal of ethanol during 
deprivation resulted in the initial decrease in breakpoint measures following access to 
ethanol. 
In conclusion, some procedural changes may need to be made in future 
experiments to observe responding and ethanol intake indicative of a clear alcohol 
deprivation effect. Oster and colleagues (2006) recently showed that three or more 
periods of deprivation were necessary for the expression of an ADE when ethanol self-
administration was placed on an operant schedule. Additionally, research has suggested 
that the length of the periods of deprivation affect the expression of an ADE (e.g., Heyser 
et al., 1997) . Therefore, three or more periods of deprivation, each at least 14 days in 
length should be implemented in future investigations of the ADE. 
The differential effects of numerous types of physiological and psychological 
stressors applied in previous research suggest that it is possible that the present route of 
administration 6f CP 55,940 or vehicle during deprivation was aversive enough to 
attenuate subsequent responding for ethanol. Intraperitoneal injection is commonly used 
to administer drugs to rats. It may be necessary, however, to investigate routes of 
administration that are less aversive, particularly when injections occur multiple times 
each day for a number of days. 
45 
The failure of the cannabinoid receptor agonist to increase the reinforcing efficacy 
of ethanol might also have been partially due to the dose administered. The dose of CP 
55,940 administered (0.03 mg/k g) has been previously shown to increase the reinfor cing 
efficacy of alcohol when it was injected just prior to testing (Gallate et al., 1999). The 
preparation used in the present experiment, however, in which chronic drug exposure 
during deprivation was followed by 2 day s with no drug may not have been sufficient to 
produce the neuroadaptive changes that research has suggested are necessary to increase 
motivation to consume another drug, including ethanol. The occurrence of any 
neurological changes, however , will remain unclear unless histological procedures are 
employed to assess the sufficiency of the administered dose. Barring the use of such 
procedures , it may be necessary to administer larger doses of CP 55,940 in future 
experim ents in which effects of chronic exposure to a cannabinoid receptor agonist are 
being investi gated. 
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